SGLT-2 inhibitors cut hospitalisations and deaths

Clinical

SGLT-2 inhibitors cut hospitalisations and deaths

In Clinical

Sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce heart failure hospitalisations by more than a third and halve all-cause mortality compared to other glucose-lowering treatments in type 2 diabetes, according to new research presented at the American College of Cardiology’s meeting in Washington.

Sponsor AstraZeneca says the study is “the first large real-world evidence study of its kind” comparing SGLT-2 inhibitors and other type 2 diabetes medicines.

The study used databases from six countries (the US, Norway, Denmark, Sweden, Germany and the UK) to match 154,523 type 2 diabetes patients taking SGLT-2 inhibitors (dapagliflozin, canagliflozin, empagliflozin) with the same number of controls taking other glucose-lowering drugs.

Most patients (87 per cent) did not have a history of cardiovascular disease. There were 961 hospitalisations for heart failure across the six countries. The German database did not yield linked mortality but in the remaining five countries, 1,334 of 215,622 patients died.

Treatment with a SGLT-2 inhibitor reduced hospital-isations for heart failure by 39 per cent (hazard ratio [HR] 0.61) and deaths from any cause by 51 per cent (HR 0.49) compared with other type 2 diabetes medicines. SGLT-2 inhibitors reduced the composite of heart failure hospitalisation or death from any cause by 46 per cent. There was no significant difference by country.

The study did not examine other cardiovascular events, such as myocardial infarction and stroke, or focus on safety. Moreover, the authors also note that experience with SGLT-2 inhibitors “in real-world practice is still relatively short”. Longer-term follow-up is therefore needed to determine whether the benefits are sustained.

Record my learning outcomes

Clinical

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Clinical

Under pressure

While the body’s need for a good night’s sleep is increasingly understood, research shows that we’re actually sleeping for less time than ever before due to anxiety and stress

6 Min Article

bookmark_icon_off
Clinical

Does OTC NRT still have a role in smoking cessation?

E-cigarettes and varenicline are associated with higher abstinence rates than other smoking cessation aids including NRT.

1 Min Article

bookmark_icon_off
Clinical

Venous leg ulcers: A silent crisis?

Described as ‘a silent crisis’ in a recent report published by the All-Party Parliamentary Group on Vascular and Venous Disease (VVAPPG), venous leg ulcers impose a heavy burden on both sufferers and the healthcare system as a whole.

5 Min Article

bookmark_icon_off
Clinical

Technology shaping community pharmacy

Patient apps, a new take on dispensary IT and the ongoing saga of hub-and-spoke are among the elements shaping the development of technology in community pharmacy.

6 Min Article

bookmark_icon_off
Clinical

Sound advice

The ears can be affected by a diverse range of problems that can all impair hearing.

6 Min Article

bookmark_icon_off
Clinical

Reacting to allergy

In a survey earlier this year GPs said that up to 90 per cent of their appointments with summer pollen sufferers were unnecessary and could be dealt with in the local pharmacy. They are absolutely right.

5 Min Article

Recommended Learning

bookmark_icon_off
Sponsored education

Advising on thrush treatment

This video looks at the distinctive benefits of different combination products and how to find the right treatment option for your customer.

7 Min Module

bookmark_icon_off
Sponsored education

Next-level parasite protection for dogs

Explore the FRONTLINE Tri-Act® active pack to learn about next-level parasite protection for dogs.

10 Min Module

bookmark_icon_off
Sponsored education

Understanding constipation treatments

Discover the key benefits of different types of laxatives, and the right questions to ask customers to ensure you know which to recommend

10 Min Module

bookmark_icon_off
Sponsored education

Pain conversations - making effective recommendations

Explore our detailed case studies to help understand how to advise customers on different causes of pain.

15 Min Module

bookmark_icon_off
Sponsored education

Relief from the nasal symptoms of allergy

With NHS England advising that OTC products should no longer be prescribed to treat mild-to-moderate hayfever, pharmacy’s role in supporting sufferers is more important than ever. This module includes self-care advice and product recommendations to aid customer conversations.

5 Min Module

bookmark_icon_off
Sponsored education

This module will help the pharmacy team to understand erectile dysfunction and its causes, and supply Viagra Connect to male customers affected by it, where appropriate

10 Min Module